Feasibility study of the LECS(Laparoscopy and Endoscopy Cooperative Surgery) to the non-ampullary duodenal tumor.

Feasibility study of the LECS(Laparoscopy and Endoscopy Cooperative Surgery) to the non-ampullary duodenal tumor. - LECS to the non-amupullary duodenal tumor

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000026726

Enrollment

Registered

2017-06-01

Start date

2017-08-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

non-ampullary duodenal tumor

Interventions

LECS to the non-ampullary tumor

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: non-amupullary adenoma or mucosal cancer, Neuroendocrine tumor, GIST 1.Satisfy the either of the following conditions Adenoma or adenoarcinoma 2.Tumor size 20-35mm 3.Impossible to perform endoscopic resection due to the ulceration scar 4.If cancer, limited to mucosal cancer GIST or NET 1.Adaptation to perform partial resection

Exclusion criteria

Exclusion criteria: 1.Advanced cancer 2.need systematic therapy of infeciton 3.need systematic therapy of anti-cancer drug. 4.need systematic thrapy of steroid 5.pregnancy or lacting 6.no more than 3 year prognosis 7.the physician judges to be inappropriate

Design outcomes

Primary

Measure	Time frame
Complication rate(post operative bleeding,dysraphia,abscess,digestive tract disoder,re-operation rate)	—

Secondary

Measure	Time frame
Operation time, hospitalization, pathological assessment of resected lesion	—

Countries

Japan

Contacts

Public ContactHiromitsu Kanzaki

Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences Gastroenterology and Hepatology

kanzaki@qc4.so-net.ne.jp086-235-7219

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026